title: Anxiety in women "at risk' of developing breast cancer.
abstract: Do family history clinics offering counselling, surveillance and preventative programmes alleviate or exacerbate anxiety in women at a high risk of developing breast cancer? In this study risk perceptions and anxiety of 99 'at risk' women participating in the Tamoxifen Prevention Trial were compared with those of 87 'at risk' women not attending any specialist clinic who were recruited from the National Breast Screening Programme (NBSP). Most anxiety was found in NBSP women with a family history. Women attending the family history clinic and participating in the trial had anxiety scores comparable with 86 women recruited from the NBSP who did not have a family history. We conclude that such specialist clinics do not see a selected group of the most anxious 'at risk' women nor does participation in tamoxifen prevention programmes appear to increase anxiety.
authors.affiliation: Department of Oncology, University College London Medical School, UK.
authors.forename: K
authors.initials: K
authors.lastname: Thirlaway
authors.forename: L
authors.initials: L
authors.lastname: Fallowfield
authors.forename: H
authors.initials: H
authors.lastname: Nunnerley
authors.forename: T
authors.initials: T
authors.lastname: Powles
mesh_terms: D000704:Analysis of Variance; D016588:Anticarcinogenic Agents / Q000627:therapeutic use*; D001007:Anxiety; D001294:Attitude to Health; D001943:Breast Neoplasms / Q000453:epidemiology / Q000235:genetics / Q000517:prevention & control; D016009:Chi-Square Distribution; D003376:Counseling; D005260:Female; D006801:Humans; D008403:Mass Screening; D010349:Patient Compliance; D018579:Patient Selection; D011897:Random Allocation; D012307:Risk Factors; D011795:Surveys and Questionnaires; D013629:Tamoxifen / Q000627:therapeutic use*
chemical_list: D016588:Anticarcinogenic Agents; D013629:Tamoxifen